COVID-19大流行期间德国2021至2023年两个不规则流行季儿童呼吸道合胞病毒感染的非典型年龄分布与高疾病严重程度
研究分析德国2021年和2022/23年5岁以下儿童RSV流行季,发现流行季不规则、RSV阳性率高于疫情前,2021年2-4岁儿童感染风险高,2022/23年住院患者重症比例升高,可能与NPIs后基线人群免疫力降低有关。
要点
- 2021年RSV阳性率40%(522/1291),高于疫情前26%(1430/5511),P<0.001。
- 2022/23年RSV阳性率30%(299/990),高于疫情前26%,P=0.005。
- 2022/23年ICU入住比例8.5%(206/2413)高于疫情前6.8%(551/8114),P=0.004。
核心结论
- 2021年2-4岁儿童RSV感染风险高,2022/23年疾病严重程度增加,可能因NPIs减少RSV暴露后基线人群免疫力降低所致。
研究设计与样本
- 通过门诊哨点监测的16754份标本调查2021年和2022/23年RSV季节性、流行谱系和受影响儿童年龄分布,并分析医院监测中RSV特异性诊断编码患者(n=13104)的疾病严重程度信息。
- 采用卡方检验评估RSV流行季间差异,采用Mann-Kendall检验分析年龄分布趋势。
主要发现
- 2021年RSV流行季为第35-50周,2022/23年为第41-3周,而COVID-19前2011/12-2019/20季节中位数为第51-12周。
- 2021年RSV阳性率40%(522/1291;p<0.001)和2022/23年30%(299/990;p=0.005)均高于此前季节的26%(1430/5511)。
- 2021年RSV-A(谱系GA2.3.5和GA2.3.6b)和2022/23年RSV-B(谱系GB5.0.5a)分别占主导。
- 2021年1-<2、2-<3、3-<4和4-<5岁儿童RSV阳性率相似。
- 2021年RSV住院发病率(1114/10万,p<0.001)和2022/23年(1034/10万,p<0.001)约为既往季节平均值(2014/15-2019/20:584/10万)的两倍。
关键数值与推荐
- 2022/23年RSV患者入住ICU比例8.5%(206/2413)高于COVID-19前季节6.8%(551/8114),p=0.004。
- 2022/23年需要呼吸机支持比例6.1%(146/2413)高于COVID-19前季节3.8%(310/8114),p<0.001。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BackgroundNon-pharmaceutical interventions (NPIs) during the COVID-19 pandemic affected respiratory syncytial virus (RSV) circulation worldwide.AimTo describe, for children aged < 5 years, the 2021 and 2022/23 RSV seasons in Germany.MethodsThrough data and 16,754 specimens from outpatient sentinel surveillance, we investigated RSV seasonality, circulating lineages, and affected children's age distributions in 2021 and 2022/23. Available information about disease severity from hospital surveillance was analysed for patients with RSV-specific diagnosis codes (n = 13,104). Differences between RSV seasons were assessed by chi-squared test and age distributions trends by Mann-Kendall test.ResultsRSV seasonality was irregular in 2021 (weeks 35-50) and 2022/23 (weeks 41-3) compared to pre-COVID-19 2011/12-2019/20 seasons (median weeks 51-12). RSV positivity rates (RSV-PR) were higher in 2021 (40% (522/1,291); p < 0.001) and 2022/23 (30% (299/990); p = 0.005) than in prior seasons (26% (1,430/5,511)). Known globally circulating RSV-A (lineages GA2.3.5 and GA2.3.6b) and RSV-B (lineage GB5.0.5a) strains, respectively, dominated in 2021 and 2022/23. In 2021, RSV-PRs were similar in 1 - < 2, 2 - < 3, 3 - < 4, and 4 - < 5-year-olds. RSV hospitalisation incidence in 2021 (1,114/100,000, p < 0.001) and in 2022/23 (1,034/100,000, p < 0.001) was approximately double that of previous seasons' average (2014/15-2019/20: 584/100,000). In 2022/23, proportions of RSV patients admitted to intensive care units rose (8.5% (206/2,413)) relative to pre-COVID-19 seasons (6.8% (551/8,114); p = 0.004), as did those needing ventilator support (6.1% (146/2,413) vs 3.8% (310/8,114); p < 0.001).ConclusionsHigh RSV-infection risk in 2-4-year-olds in 2021 and increased disease severity in 2022/23 possibly result from lower baseline population immunity, after NPIs diminished exposure to RSV.
引用
- Cai W, Köndgen S, Tolksdorf K, et al. Atypical age distribution and high disease severity in children with RSV infections during two irregular epidemic seasons throughout the COVID-19 pandemic, Germany, 2021 to 2023. Euro Surveill. 2024. PMID: 38551098. doi:10.2807/1560-7917.ES.2024.29.13.2300465
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。